← Back to Clinical Trials
Recruiting NCT06836986

NCT06836986 COMPARISON BETWEEN EFFICACY OF NOREPINEPHRINE AND PHENYLEPHRINE BOLUSES for PREVENTION OF SPINAL ANAESTHESIA INDUCED HYPOTENSION IN OBSTETRICAL PATIENTS UNDERGOING EMERGENCY CESAREAN SECTION-A Double Blind Randomized Controlled Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06836986
Status Recruiting
Phase
Sponsor Dow University of Health Sciences
Condition Spinal Anesthesia Induced Hypotension
Study Type INTERVENTIONAL
Enrollment 124 participants
Start Date 2024-12-31
Primary Completion 2025-03-31

Trial Parameters

Condition Spinal Anesthesia Induced Hypotension
Sponsor Dow University of Health Sciences
Study Type INTERVENTIONAL
Phase N/A
Enrollment 124
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2024-12-31
Completion 2025-03-31
Interventions
Norepinephrine BolusPhenylephrine bolus

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if norepinephrine is more effective than phenylephrine for prevention of spinal anesthesia induced hypotension. The main questions it aims to answer are: Does norepinephrine lower the incidence of spinal anesthesia induced hypotension in emergency obstetrical patients? We will compare effectiveness of norepinephrine and phenylephrine for the prevention of spinal anesthesia induced hypotension. Participants will: Be administered prophylactic boluses of both drugs right after spinal anesthesia induction and maternal hemodynamic parameters and neonatal APGAR scores will be recorded

Eligibility Criteria

Inclusion Criteria: 1. American society of anesthesiologists II and III patients 2. Age 18-40years 3. Gestational age 32 weeks and above Exclusion Criteria: 1. Patients with hypertensive disorders of pregnancy having baseline systolic blood pressure greater than 160 mmHg and diastolic blood pressure greater than 99 mmHg. 2. Baseline mean arterial pressure less than 70 mmHg. 3. Antepartum hemorrhage/intraoperative blood loss greater than 1000ml 4. history indicative of cardiovascular or neurological disease. 5. known fetal abnormality. 6. Patients taking serotonin reuptake inhibitor, Tricyclic antidepressants,monoamine oxidase inhibitors. 7. Maternal situations requiring immediate administration of general anesthesia

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology